• 1
    Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001; 36: 215.
  • 2
    Hildebrand H, Finkel Y, Grahnquist L, Lindholm J, Ekbom A, Askling J. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001. Gut 2003; 52: 14324.
  • 3
    Phavichitr N, Cameron DJS, Catto-Smith AG. Increasing incidence of Crohn's disease in Victorian children. J Gastroenterol Hepatol 2003; 18: 32932.
  • 4
    Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63: 7415.
  • 5
    Probert CS, Jayanthi V, Pollock DJ, Baithun SI, Mayberry JF, Rampton DS. Crohn's disease in Bangladeshis and Europeans in Britain: an epidemiological comparison in Tower Hamlets. Postgrad Med J 1992; 68: 91420.
  • 6
    Jayanthi V, Probert CS, Pinder D, Wicks AC, Mayberry JF. Epidemiology of Crohn's disease in Indian migrants and the indigenous population in Leicestershire. Q J Med 1992; 82: 12538.
  • 7
    Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11: 5436.
  • 8
    Heckers H, Melcher FW, Kamenisch W, Henneking K. Chemically prepared fats and Crohn disease. A pilot study of occurrence of trans-fatty acids in the subcutaneous tissue of patients in comparison with healthy controls as a parameter of long-term fat intake. Z Gastroenterol 1988; 26: 25964.
  • 9
    Chuah SY, Jayanthi V, Lee CN, McDonald B, Probert CS, Mayberry JF. Dietary fats and inflammatory bowel disease in Asians. Ital J Gastroenterol 1992; 24: 3868.
  • 10
    Geerling BJ, v Houwelingen AC, Badart-Smook A, Stockbrugger RW, Brummer RJ. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am J Gastroenterol 1999; 94: 4107.
    Direct Link:
  • 11
    Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992; 3: 4752.
  • 12
    Gee MI, Grace MG, Wensel RH, Sherbaniuk RW, Thomson AB. Nutritional status of gastroenterology outpatients: comparison of inflammatory bowel disease with functional disorders. J Am Diet Assoc 1985; 85: 15919.
  • 13
    Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 1976; 54: 36771.
  • 14
    Rawcliffe PM, Truelove SC. Breakfast and Crohn's disease – I. Br Med J 1978; 2: 53940.
  • 15
    Kasper H, Sommer H. Dietary fiber and nutrient intake in Crohn's disease. Am J Clin Nutr 1979; 32: 1898901.
  • 16
    Thornton JR, Emmett PM, Heaton KW. Diet and Crohn's disease: characteristics of the pre-illness diet. Br Med J 1979; 2: 7624.
  • 17
    Silkoff K, Hallak A, Yegena L, et al. Consumption of refined carbohydrate by patients with Crohn's disease in Tel-Aviv-Yafo. Postgrad Med J 1980; 56: 8426.
  • 18
    Mayberry JF, Rhodes J, Newcombe RG. Increased sugar consumption in Crohn's disease. Digestion 1980; 20: 3236.
  • 19
    Mayberry JF, Rhodes J, Allan R, et al. Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981; 26: 4448.
  • 20
    Jarnerot G, Jarnmark I, Nilsson K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983; 18: 9991002.
  • 21
    Katschinski B, Logan RF, Edmond M, Langman MJ. Smoking and sugar intake are separate but interactive risk factors in Crohn's disease. Gut 1988; 29: 12026.
  • 22
    Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international co-operative study. Scand J Gastroenterol 1987; 22: 100924.
  • 23
    Matsui T, Iida M, Fujishima M, Imai K, Yao T. Increased sugar consumption in Japanese patients with Crohn's disease. Gastroenterol Jpn 1990; 25: 271.
  • 24
    Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7: 4751.
  • 25
    Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997; 40: 75460.
  • 26
    Sakomoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicentre case-control study in Japan. Inflamm Bowel Dis 2005; 11: 15463.
  • 27
    Mayberry JF, Rhodes J, Allan R, et al. Breakfast and dietary aspects of Crohn's disease. Br Med J 1978; 2: 1401.
  • 28
    Kasper H, Sommer H. Taste thresholds in patients with Crohn's disease. J Hum Nutr 1980; 34: 4556.
  • 29
    Brauer PM, Gee MI, Grace M, Thomson AB. Diet of women with Crohn's and other gastrointestinal diseases. J Am Diet Assoc 1983; 82: 65964.
  • 30
    Penny WJ, Mayberry JF, Aggett PJ, Gilbert JO, Newcombe RG, Rhodes J. Relationship between trace elements, sugar consumption, and taste in Crohn's disease. Gut 1983; 24: 28992.
  • 31
    Porro GN, Panze E. Smoking, sugar and inflammatory bowel disease. Br Med J 1985; 291: 9712.
  • 32
    Probert CS, Bhakta P, Bhamra B, Jayanthi V, Mayberry JF. Diet of South Asians with inflammatory bowel disease. Arq Gastroenterol 1996; 33: 1325.
  • 33
    Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998; 52: 22938.
  • 34
    Nicklas TA, Webber LS, Srinivasan SR, Berenson GS. Secular trends in dietary intakes and cardiovascular risk factors of 10-y-old children: the Bogalusa Heart Study (1973–1983). Am J Clin Nutr 1993; 57: 9307.
  • 35
    Gibney M, Sigman-Grant M, Stanton JL, Keast DR. Consumption of sugars. Am J Clin Nutr 1995; 62 (Suppl.): 178S93.
  • 36
    Nielsen SM, Siega-Riz AM, Popkin BM. Trends in energy intake in US between 1977 and 1996: similar shifts seen across age groups. Obesity Res 2002; 10: 3708.
  • 37
    Kennedy ET, Shanthy SA, Powell R. Dietary-fat intake in the US population. J Am Coll Nutr 1999; 18: 20712.
  • 38
    Alexy U, Sichert-Hellert W, Kersting M. Fifteen-year time trends in energy and macronutrient intake in German children and adolescents: results of the DONALD study. Br J Nutr 2002; 87: 595604.
  • 39
    Osler M, Heitmann BL, Schroll M. Ten year trends in the dietary habits of Danish men and women. Cohort and cross-sectional data. Eur J Clin Nutr 1997; 51: 53541.
  • 40
    Popkin BM, Nielsen SM. The sweetening of the world's diet. Obesity Res 2003; 11: 132532.
  • 41
    Guthrie JF, Morton JF. Food sources of added sweeteners in the diets of Americans. J Am Diet Assoc 2000; 100: 438.
  • 42
    Meddings JB, Gibson PR, Tagkalidis P. Mucosal defenses and intestinal permeability. In: Satsangi, J, Sutherland, LR, eds. Inflammatory Bowel Diseases. Edinburgh: Churchill Livingstone, 2003: 6383.
  • 43
    Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiological factor. Ann Intern Med 1986; 105: 8835.
  • 44
    Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989; 97: 92731.
  • 45
    May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relations of patients with Crohn's disease? Gastroenterology 1993; 104: 162732.
  • 46
    Peeters M, Geypens B, Claus D, et al. Clustering of increased small intestinal permeability in family with Crohn's disease. Gastroenterology 1997; 113: 8027.
  • 47
    Soderholm JD, Olaison G, Lindberg E, et al. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut 1999; 44: 96100.
  • 48
    Secondulfo M, de Magistris L, Fiandra R, et al. Intestinal permeability in Crohn's disease patients and their first degree relatives. Dig Liver Dis 2001; 33: 6805.
  • 49
    Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 1996; 110: 1395403.
  • 50
    Zamora SA, Hilsden RJ, Meddings JB, Butzner JD, Scott RB, Sutherland LR. Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Can J Gastroenterol 1999; 13: 316.
  • 51
    Yacyshyn BR, Meddings JB. CD45RO expression on circulating CD19+ B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology 1995; 108: 1327.
  • 52
    Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 2000; 119: 17404.
  • 53
    Breslin NP, Nash C, Hilsden RJ, et al. Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease. Am J Gastroenterol 2001; 96: 29348.
    Direct Link:
  • 54
    Keshavarzian A, Choudhary S, Holmes EW, et al. Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther 2001; 299: 42248.
  • 55
    Mariadason JM, Catto-Smith A, Gibson PR. Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats. Gut 1999; 44: 3949.
  • 56
    Spaeth G, Berg RD, Specian RD. Food without fiber promotes bacterial translocation from the gut. Surgery 1990; 108: 2407.
  • 57
    Frankel W, Zhang W, Singh A, et al. Fiber: effects on bacterial translocation and intestinal mucin content. World J Surg 1995; 19: 1448.
  • 58
    Argenzio RA, Meulen DJ. Short-chain fatty acids induce reversible injury of porcine colon. Dig Dis Sci 1991; 36: 145968.
  • 59
    Remesy C, Levrat MA, Gamet L, Demigne C. Cecal fermentations in rats fed oligosaccharides (inulin) are modulated by dietary calcium level. Am J Physiol 1993; 364: G85562.
  • 60
    Bovee-Oudenhoven IM, ten Bruggencate SJ, Lettink-Wissink ML, van der Meer R. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation in rats. Gut 2003; 52: 15728.
  • 61
    Mullin JM, Valenzano MC, Verrecchio JJ, Kothari A. Age-and diet-related increase in transepithelial colon permeability of Fischer 344 rats. Dig Dis Sci 2002; 47: 226270.
  • 62
    Vine DF, Charman SA, Gibson PR, Sinclair AJ, Porter CJ. Effect of dietary fatty acids on the intestinal permeability of marker drug compounds in excised rat jejunum. J Pharm Pharmacol 2002; 54: 80919.
  • 63
    Rumessen JJ, Gudmand-Hoyer E. Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 1986; 27: 11618.
  • 64
    Rumessen JJ, Gudmand-Hoyer E. Functional bowel disease: malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988; 95: 694700.
  • 65
    Ravich W, Bayless T, Thomas M. Fructose: incomplete intestinal absorption in humans. Gastroenterology 1983; 84: 269.
  • 66
    Roberfroid MB, Delzenne NM. Dietary fructans. Ann Rev Nutr 1998; 18: 11743.
  • 67
    Roberfroid MB. Concepts in functional foods: the case of inulin and oligofructose. J Nutr 1999; 129 (Suppl. 7): 1398S401.
  • 68
    Moshfegh AJ, Friday JE, Goldman JP, Ahuja JK. Presence of inulin and oligofructose in the diets of Americans. J Nutr 1999; 129: 1407S11.
  • 69
    Rumessen JJ, Gudmand-Hoyer E. Fructans of chicory: intestinal transport and fermentation of different chain lengths and relation to fructose and sorbitol malabsorption. Am J Clin Nutr 1998; 68: 35764.
  • 70
    Vesa TH, Marteau P, Korpela R. Lactose intolerance. J Am Coll Nutr 2000; 19 (Suppl.): 165S75.
  • 71
    Hyams JS. Sorbitol intolerance: an unappreciated cause of functional gastrointestinal complaints. Gastroenterology 1983; 84: 303.
  • 72
    Beaugerie L, Flourie B, Marteau P, Pellier P, Franchisseur C, Rambaud JC. Digestion and absorption in the human intestine of three sugar alcohols. Gastroenterology 1990; 99: 71723.
  • 73
    Matthews RH, Pehrsson PR, Farhat-Sabet M. Sugar Content of Selected Foods: Individual and Total Sugars. Washington, D.C.: United States Department of Agriculture, Human Nutrition Information Service, Report No. 48, 1987.
  • 74
    Steggerda FR, Richards EA, Rackis JJ. Effects of various soybean products on flatulence in the adult man. Proc Soc Exp Biol Med 1966; 121: 12359.
  • 75
    Suarez FL, Springfield J, Furne JK, Lohrmann TT, Kerr PS, Levitt MD. Gas production in humans ingesting a soybean flour derived from beans naturally low in oligosaccharides. Am J Clin Nutr 1999; 69: 1359.
  • 76
    Franck A. Technological functionality of inulin and oligofructose. Br J Nutr 2002; 87 (Suppl. 2): S28791.
  • 77
    Rumessen JJ. Fructose and related food carbohydrates. Sources, intake, absorption, and clinical implications. Scand J Gastroenterol 1992; 27: 81928.
  • 78
    Roberfroid MB. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 1998; 128: 119.
  • 79
    Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108: 97582.
  • 80
    Nyman M. Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br J Nutr 2002; 87 (Suppl. 2): S1638.
  • 81
    Kaur N, Gupta AK. Applications of inulin and oligofructose in health and nutrition. J Biosci 2002; 27: 70314.
  • 82
    Reddy BS, Hamid R, Rao CV. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 1997; 18: 13714.
  • 83
    Reddy BS. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies. Br J Nutr 1998; 80: S21923.
  • 84
    Femia AP, Luceri C, Dolara P, et al. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifibdobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 2002; 23: 195360.
  • 85
    Verghese M, Rao DR, Chawan CB, Shackelford L. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J Nutr 2002; 132: 28048.
  • 86
    Buddington KK, Donahoo JB, Buddington RK. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J Nutr 2002; 132: 4727.
  • 87
    Brighenti F, Casiraghi MC, Pellegrini N, Riso P, Simonetti P, Testolin G. Comparison of lactulose and inulin as reference standard for the study of resistant starch using hydrogen breath test. Ital J Gastroenterol 1995; 27: 1228.
  • 88
    O'Leary C, Quigley EM. Small bowel bacterial overgrowth, celiac disease, and IBS: what are the real associations? Am J Gastroenterol 2003; 98: 7202.
    Direct Link:
  • 89
    Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 35036.
    Direct Link:
  • 90
    Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome, a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003; 98: 4129.
  • 91
    Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol 2003; 98: 83943.
    Direct Link:
  • 92
    Castiglione F, Rispo A, Di Girolamo E, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther 2003; 18: 110712.
  • 93
    Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Van Der Meer R. Dietary fructo-oligosaccharides increase intestinal permeability in rats. In: Ten Bruggencate, SJM, ed. Dietary Non-digestible Carbohydrates and the Resistance to Intestinal Infections. PhD thesis. The Netherlands: Wageningen University, 2004: 91108.
  • 94
    Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Van Der Meer R. Dietary fructo-oligosaccharides and the intestinal barrier in humans. In: Ten Bruggencate, SJM, ed. Dietary Non-digestible Carbohydrates and the Resistance to Intestinal Infections. PhD thesis. The Netherlands: Wageningen University, 2004: 10926.
  • 95
    Ten Bruggencate SJM, Bovee-Oudenhoven IMJ, Lettink-Wissink MLG, Katan MB, Van Der Meer R. Dietary fructo-oligosaccharides and inulin decrease resistance of rats to salmonella: protective role of calcium. Gut 2004; 53: 5305.
  • 96
    Hughes R, Rowland IR. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis 2001; 22: 437.
  • 97
    Gibson PR. Apoptosis or necrosis – colonic epithelial cell survival. In: Inflammatory Bowel Disease – Crossroads between Microbes, Epithelium, and Immune Systems. Chichester: Wiley (Novartis Foundation Symposium 263); 2004: 13350.
  • 98
    McIntyre A, Young GP, Taranto T, Gibson PR, Ward PB. Different fibers have different regional effects on luminal contents of rat colon. Gastroenterology 1991; 101: 127481.
  • 99
    Young GP, McIntyre A, Albert V, Folino M, Muir JG, Gibson PR. Wheat bran suppresses potato-starch potentiated tumorigenesis at the aberrant crypt stage in a rat model of colorectal cancer. Gastroenterology 1996; 100: 50814.
  • 100
    Govers MJAP, Gannon NJ, Dunshea FR, Gibson PR, Muir JG. Wheat bran affects the site of fermentation of resistant starch and luminal indices related to colon cancer risk: a study in pigs. Gut 1999; 45: 8407.
  • 101
    Muir JG, Yeow EGW, Keogh J, et al. Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone. Am J Clin Nutr 2004; 79: 10208.
  • 102
    Gibson PR, Nov R, Fielding M, et al. The relationship of hydrolase activities to epithelial cell turnover in distal colonic mucosa of normal rats. J Gastroenterol Hepatol 1999; 14: 86672.
  • 103
    Lu ZX, Gibson PR, Muir JG, et al. Arabinoxylan fiber from a by-product of wheat flour processing behaves physiologically like a soluble, fermentable fiber in the large bowel of rats. J Nutr 2000; 130: 198490.
  • 104
    Piche T, des Varannes SB, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 2003; 124: 894902.
  • 105
    Ledochowski M, Widner B, Sperner-Unterweger B, Propst T, Vogel W, Fuchs D. Carbohydrate malabsorption syndromes and early signs of mental depression in females. Dig Dis Sci 2000; 45: 12559.
  • 106
    Ledochowski M, Widner B, Bair H, Probst T, Fuchs D. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 2000; 35: 104852.
  • 107
    Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D. Fructose malabsorption is associated with decreased plasma tryptophan. Scand J Gastroenterol 2001; 36: 36771.